
Subhrab D 30mg/20mg Capsule SR
Marketer
Subhyog Pharmaceutical Private Limited
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Subhrab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with Subhrab D 30mg/20mg SR capsules, a dual-action formulation. This medication alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Subhrab D 30mg/20mg SR capsules should strictly follow your physician's instructions, tailored to your individual needs and response. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Always disclose all other medications you're using to your healthcare provider, as interactions are possible. Common side effects, such as diarrhea, abdominal discomfort, dry mouth, headache, gas, and fatigue, are typically transient. However, report any concerning side effects immediately. Drowsiness and dizziness may occur; refrain from driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, including consuming cold milk and avoiding caffeine, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any existing kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Subhrab D 30mg/20mg Capsule SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Subhrab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Subhrab D 30mg/20mg Capsule SR:
Follow your physician's instructions precisely regarding dosage and treatment length for Subhrab D 30mg/20mg SR Capsules. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Subhrab D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Subhrab D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Subhrab D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Subhrab D 30mg/20mg Capsule SR works:
Subhrab D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with a proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating efficient food passage. Rabeprazole decreases gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Subhrab D 30mg/20mg SR capsules with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Using Subhrab D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Using Subhrab D 30mg/20mg SR capsules while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Subhrab D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Subhrab D 30mg/20mg sustained-release capsules. Dosage modification for Subhrab D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Subhrab D 30mg/20mg SR capsules cautiously, potentially requiring dosage modification. Medical advice is essential. Subhrab D 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Subhrab D 30mg/20mg Capsule SR :
Should you forget to take a Subhrab D 30mg/20mg Capsule SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Subhrab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
